AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glucotaj Met 2mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Taj Pharma India Ltd

Salt Composition

Glimepiride (2mg) + Metformin (1000mg)

Overview Glucotaj Met 2mg/1000mg Tablet SR

Diabetak Duo 2mg/1000mg Extended-Release Tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabetak Duo should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Knowing how to manage hypoglycemia, including regular meals and carrying a fast-acting glucose source (e.g., sugary snacks or juice), is essential. Alcohol consumption increases hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical advice before use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Glucotaj Met 2mg/1000mg Tablet SR

No information provided. Therefore, no text can be rewritten.

Uses of Glucotaj Met 2mg/1000mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glucotaj Met 2mg/1000mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for Glucotaj Met 2mg/1000mg SR tablets. Ingest the tablets whole; do not fracture, pulverize, or chew them. Consume with a meal.

Common Side effects of Glucotaj Met 2mg/1000mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glucotaj Met 2mg/1000mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glucotaj Met 2mg/1000mg SR tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Glucotaj Met 2mg/1000mg Tablet SR works:

Glucotaj Met SR tablets (2mg/1000mg) combine the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Glucotaj Met 2mg/1000mg SR tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glucotaj Met 2mg/1000mg SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The extended-release Glucotaj Met 2mg/1000mg tablet is contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glucotaj Met 2mg/1000mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glucotaj Met 2mg/1000mg SR tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glucotaj Met 2mg/1000mg SR tablets cautiously. Dosage modification may be necessary. A physician's consultation is advised. For those with mild to moderate liver disease, Glucotaj Met 2mg/1000mg SR tablets are typically initiated at a low dose; however, their use is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glucotaj Met 2mg/1000mg Tablet SR :

Should you forget to take your Glucotaj Met 2mg/1000mg SR tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glucotaj Met 2mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glucotaj Met 2mg/1000mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glucotaj Met 2mg/1000mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glucotaj Met and seek immediate medical attention.
Glucotaj Met 2mg/1000mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glucotaj Met 2mg/1000mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach upset, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glucotaj Met 2mg/1000mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glucotaj Met 2mg/1000mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glucotaj Met 2mg/1000mg SR tablets with alcohol is unsafe. Alcohol can dangerously lower blood sugar, causing hypoglycemia, and may increase the risk of lactic acidosis.
Glucotaj Met 2mg/1000mg T...
138
MRP 160
13% off